Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
792.37
686.60
619.55
514.83
393.79
261.21
192.29
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
792.37
686.60
619.55
514.83
393.79
261.21
192.29
Raw Material Cost
289.98
265.98
203.63
149.27
101.09
73.24
63.90
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
104.74
85.24
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.36
4.50
2.99
0.60
0.00
0.83
0.28
Selling and Distribution Expenses
255.83
242.96
209.00
181.63
0.00
82.67
72.89
Other Expenses
8.01
7.77
9.15
8.09
0.00
-5.74
-5.52
Total Expenditure (Excl Depreciation)
632.32
591.15
507.12
412.37
101.09
204.13
167.09
Operating Profit (PBDIT) excl Other Income
160.10000000000002
95.5
112.4
102.5
292.7
57.1
25.2
Other Income
24.26
33.01
49.80
75.81
0.00
42.98
25.13
Operating Profit (PBDIT)
266.77
221.44
223.17
222.86
143.26
110.54
54.49
Interest
6.36
4.50
2.99
0.60
0.00
0.83
0.28
Exceptional Items
0.69
2.34
2.73
-0.05
0.00
0.00
0.18
Gross Profit (PBDT)
502.38
420.62
415.91
365.56
292.70
187.97
128.39
Depreciation
90.94
96.91
62.29
47.00
0.00
18.35
7.53
Profit Before Tax
170.16
122.37
160.63
175.22
143.31
91.35
46.86
Tax
22.29
9.40
2.37
9.02
18.39
14.92
12.13
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
142.64
109.82
158.91
164.67
124.93
76.43
34.74
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
142.64
109.82
158.91
164.67
124.93
76.43
34.74
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
-0.01
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
142.64
109.82
158.91
164.67
124.93
76.43
34.73
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,227.20
2,134.73
2,124.66
1,977.71
785.63
657.24
240.47
Earnings per share (EPS)
0.35
0.27
0.39
0.4
0.3
0.19
0.08
Diluted Earnings per share
0.35
0.27
0.39
0.4
0.3
0.19
0.08
Operating Profit Margin (Excl OI)
19.13%
13.33%
17.93%
19.43%
36.38%
18.84%
11.35%
Gross Profit Margin
32.95%
31.94%
35.98%
43.16%
36.39%
42.0%
28.29%
PAT Margin
18.0%
15.99%
25.65%
31.98%
31.72%
29.26%
18.07%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 15.41% vs 10.83% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 29.87% vs -30.90% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 28.72% vs 8.65% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 42.22% vs 50.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of GemPharmatech Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
792.37
0
792.37
Other Operating Income
0.00
0.00
0.00
Total Operating income
792.37
0
792.37
Raw Material Cost
289.98
0
289.98
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
6.36
0
6.36
Selling and Distribution Expenses
255.83
0
255.83
Other Expenses
8.01
0.00
8.01
Total Expenditure (Excl Depreciation)
632.32
0
632.32
Operating Profit (PBDIT) excl Other Income
160.05
0.00
160.05
Other Income
24.26
0
24.26
Operating Profit (PBDIT)
266.77
0
266.77
Interest
6.36
0
6.36
Exceptional Items
0.69
0
0.69
Gross Profit (PBDT)
502.38
0
502.38
Depreciation
90.94
0
90.94
Profit Before Tax
170.16
0
170.16
Tax
22.29
0
22.29
Provisions and contingencies
0
0
0.00
Profit After Tax
142.64
0
142.64
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
142.64
0
142.64
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
142.64
0
142.64
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,227.20
0
2,227.20
Earnings per share (EPS)
0.35
0
0.35
Diluted Earnings per share
0.35
0
0.35
Operating Profit Margin (Excl OI)
19.13%
0%
0.00
19.13%
Gross Profit Margin
32.95%
0%
0.00
32.95%
PAT Margin
18.00%
0%
0.00
18.00%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 79.24 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 15.41% vs 10.83% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 14.26 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 29.87% vs -30.90% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 24.25 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 28.72% vs 8.65% in Dec 2024
Annual - Interest
Interest 0.64 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 42.22% vs 50.00% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.13%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






